Published in Nucleic Acids Res on November 28, 2016
Multiplex genome engineering using CRISPR/Cas systems. Science (2013) 55.53
Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res (2011) 16.53
Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol (2009) 12.40
Human CtIP promotes DNA end resection. Nature (2007) 10.63
The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem (2010) 9.80
Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol (2007) 9.23
Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell (2009) 8.97
A rapid and general assay for monitoring endogenous gene modification. Methods Mol Biol (2010) 6.77
Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell (2011) 6.56
Regulation of DNA double-strand break repair pathway choice. Cell Res (2008) 6.19
Homologous recombination in human embryonic stem cells. Nat Biotechnol (2003) 5.77
A role for LEDGF/p75 in targeting HIV DNA integration. Nat Med (2005) 4.88
Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity. Neuron (1999) 4.68
TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction. Nucleic Acids Res (2012) 4.45
Regulation of homologous recombination in eukaryotes. Annu Rev Genet (2010) 4.33
A guide to genome engineering with programmable nucleases. Nat Rev Genet (2014) 4.15
Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. Cell Stem Cell (2013) 4.05
Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Nat Biotechnol (2015) 3.64
Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease. Blood (2011) 3.43
Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs. Cell Stem Cell (2011) 3.32
Mitosis inhibits DNA double-strand break repair to guard against telomere fusions. Science (2014) 3.31
Optimization of scarless human stem cell genome editing. Nucleic Acids Res (2013) 2.78
Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells. Nat Biotechnol (2015) 2.77
In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases. Stem Cells (2011) 2.52
High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J Virol (1998) 2.47
Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication. J Biol Chem (2005) 2.44
WASP: a key immunological multitasker. Nat Rev Immunol (2010) 2.38
Site-specific integration and tailoring of cassette design for sustainable gene transfer. Nat Methods (2011) 2.30
Identification and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF/p75. J Mol Biol (2006) 2.13
CtIP links DNA double-strand break sensing to resection. Mol Cell (2009) 2.11
Clinical course of patients with WASP gene mutations. Blood (2003) 2.06
Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors. Nat Biotechnol (2015) 2.03
Engineering of human pluripotent stem cells by AAV-mediated gene targeting. Mol Ther (2010) 1.99
Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication. J Virol (2006) 1.82
A mouse geneticist's practical guide to CRISPR applications. Genetics (2014) 1.81
Adenoviral vector DNA for accurate genome editing with engineered nucleases. Nat Methods (2014) 1.74
Targeted genome modifications using integrase-deficient lentiviral vectors. Mol Ther (2007) 1.60
Small molecules enhance CRISPR genome editing in pluripotent stem cells. Cell Stem Cell (2015) 1.49
Trisomy correction in Down syndrome induced pluripotent stem cells. Cell Stem Cell (2012) 1.35
LEDGF (p75) promotes DNA-end resection and homologous recombination. Nat Struct Mol Biol (2012) 1.27
Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors. Nat Biotechnol (2015) 1.17
Targeted gene addition in human epithelial stem cells by zinc-finger nuclease-mediated homologous recombination. Mol Ther (2013) 1.10
Efficient and accurate homologous recombination in hESCs and hiPSCs using helper-dependent adenoviral vectors. Mol Ther (2011) 1.06
Human intestinal tissue with adult stem cell properties derived from pluripotent stem cells. Stem Cell Reports (2014) 0.98
Structural properties of HIV integrase. Lens epithelium-derived growth factor oligomers. J Biol Chem (2010) 0.98
Precise gene modification mediated by TALEN and single-stranded oligodeoxynucleotides in human cells. PLoS One (2014) 0.88
The nontoxic cell cycle modulator indirubin augments transduction of adeno-associated viral vectors and zinc-finger nuclease-mediated gene targeting. Hum Gene Ther (2012) 0.86
Dissecting the mechanism of histone deacetylase inhibitors to enhance the activity of zinc finger nucleases delivered by integrase-defective lentiviral vectors. Hum Gene Ther (2014) 0.79
Comparison Between Several Integrase-defective Lentiviral Vectors Reveals Increased Integration of an HIV Vector Bearing a D167H Mutant. Mol Ther Nucleic Acids (2014) 0.76